GLP-one agonists mimic the way a hormone identified as glucagon-like peptide 1 works in the human body. When blood sugar starts to increase just after a person eats, these medicines trigger the body to make a lot more insulin. The additional insulin helps reduced blood sugar. Insulin injectio